Evidence map›Paper›PMID 34075041›Full record

ArticleNature communications2021

EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells.

Suyasha Roy, Zaigham Abbas Rizvi, Alexander J Clarke, Felicity Macdonald, Abhaydeep Pandey, Dietmar Martin Werner Zaiss, Anna Kathrina Simon, Amit Awasthi

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Natural lung-tropic TJournal for immunotherapy of cancer · 2024
    Article
  15. Intratumoral CXCL13Journal for immunotherapy of cancer · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Suyasha RoyImmuno-biology Laboratory, Translational Health Science & Technology Institute, Faridabad, Haryana, India.ORCID http://orcid.org/0000-0002-0332-4962
Zaigham Abbas RizviImmuno-biology Laboratory, Translational Health Science & Technology Institute, Faridabad, Haryana, India.
Alexander J ClarkeKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2846-7860
Felicity MacdonaldInstitute of Immunology and Infection Research, University of Edinburgh, Scotland, UK.
Abhaydeep PandeyTranslational Health Science & Technology Institute, Faridabad, Haryana, India.
Dietmar Martin Werner ZaissInstitute of Immunology and Infection Research, University of Edinburgh, Scotland, UK.
Anna Kathrina SimonKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Amit AwasthiImmuno-biology Laboratory, Translational Health Science & Technology Institute, Faridabad, Haryana, India. aawasthi@thsti.res.in.ORCID http://orcid.org/0000-0002-2563-1971
Translational Health Science and Technology Institute · INUniversity of Edinburgh · GBUniversity of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Interleukin 9 (IL-9)-producing helper T (Th9) cells are essential for inducing anti-tumor immunity and inflammation in allergic and autoimmune diseases. Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored. Here, we identify that Epidermal Growth Factor Receptor (EGFR) is essential for IL-9 induction in helper T (Th) cells. Moreover, amphiregulin (Areg), an EGFR ligand, is critical for the amplification of Th9 cells induced by TGF-β1 and IL-4. Furthermore, our data show that Areg-EGFR signaling induces HIF1α, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells. Loss of EGFR or HIF1α abrogates Th9 cell differentiation and suppresses their anti-tumor functions. Moreover, in line with its reliance on HIF1α expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.

Indexed as

AmphiregulinAnimalsCell DifferentiationErbB ReceptorsFemaleHealthy VolunteersHEK293 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitImmunotherapy, AdoptiveInterleukin-9Melanoma, ExperimentalMiceMice, KnockoutNitric Oxide Synthase Type IIPrimary Cell CultureAmphiregulinAreg protein, mouseEGFR protein, humanEGFR protein, mouseErbB ReceptorsHIF1A protein, humanHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitInterleukin-9Nitric Oxide Synthase Type IINos2 protein, mouseSuccinic Acid

Identifiers

PMID34075041
PMCPMC8169867
OpenAlexW3163950695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.